Related Experiment Video
Updated: Jul 15, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Limb salvage surgery for osteosarcoma: effective low-cost treatment
Manish Agarwal1, Chetan Anchan, Mandip Shah
1Department of Surgery, Tata Memorial Hospital, Mumbai, India. mgagarwal@gmail.com
This study shows that low-cost limb salvage surgery and chemotherapy can effectively manage osteosarcoma in developing countries. Limb salvage surgery is now the standard of care for treating this challenging bone cancer.
Area of Science:
- Orthopedic Oncology
- Surgical Innovation
- Global Health
Background:
- Osteosarcoma management in developing nations presents significant challenges.
- Limb salvage surgery offers a potential alternative to amputation.
Purpose of the Study:
- To evaluate the early outcomes of a cost-effective limb salvage surgery protocol for high-grade osteosarcoma.
- To assess the feasibility of using custom-designed megaprostheses in resource-limited settings.
Main Methods:
- Prospective data collection of 135 high-grade osteosarcoma patients treated between 2000-2004.
- Neoadjuvant chemotherapy (excluding methotrexate) followed by limb salvage surgery.
- Use of custom-fabricated stainless steel megaprostheses in 78 patients.
Main Results:
- Follow-up data available for 120 patients (24-72 months).
- 61% of patients were disease-free at follow-up.
- Functional scores averaged 85% for lower extremity and 66% for shoulder reconstructions.
Conclusions:
- Osteosarcoma can be effectively managed in developing countries using a cost-effective limb salvage approach.
- Limb salvage surgery, combined with tailored chemotherapy, is a viable and increasingly standard treatment option.
- Custom megaprostheses demonstrate acceptable outcomes despite challenges in resource-limited environments.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018